Press Release

U.S. 3D Bioprinting Market to Touch USD 1,887 Million Mark by 2030 Due to Increasing Application in the Pharmaceutical Industry

The U.S. 3D Bioprinting Market size was valued at around USD688 million in 2024 and is projected to reach USD1,887 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 17.88% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. The widespread application of 3D printed models in the cosmetics and pharmaceutical industries is the main reason behind the surge of this market. The products manufactured by these industries are tested on models having the same structure as the human body and react similarly, thereby reducing the expense and time of the development and thus resulting in higher sales of 3D bioprinting machines year on year.

Additionally, the implementation of the FDA Modernization Act 2.0, drug testing on animals was in 2022 by the US government. This posed challenges for life sciences companies as it was mandatory for them to test new drugs and their effect on the body before launching them in the market, to get a better idea of their performance, so that it does not turn out to be a failure. This challenge is addressed by the use of 3D-printed tissues, models, and cells, as they are similar to those present in the human body and help in knowing the precise impacts of the solutions developed. As a result, the sales of 3D bioprinters increase as they are used to develop such models and structures, and this demand is expected to grow in the coming years as well due to the increasing number of new solutions launched.

Furthermore, there is a very high focus in the US on R&D processes, which can be observed from multiple drug approvals done by the FDA. For instance, the FDA has approved 55 new drugs in 2023 and 50 new drugs in 2024. As a result, the demand for 3D bioprinting devices increases as models made by them are highly used in such research processes for developing and measuring the impact of new drugs. Therefore, the market has witnessed high growth in past years due to the superior advantages offered by 3D bioprinting to various industries including pharmaceuticals and cosmetics, and this trend is expected to continue in the forecast period as well due to the increasing investments in R&D processes and the governmental support, further states the research report, “U.S. 3D Bioprinting Market Analysis, 2025.”

U.S. 3D Bioprinting Market Segmentation Analysis

Research Applications Hold a Major Market Share

Based on the application of 3D bioprinting, the market is further bifurcated into Research Applications and Clinical Applications. Here, research applications lead the market with a share of around 70%. This is because various pharmaceutical companies are present in the United States that are highly inclined towards developing new medicines with multiple functionalities. As 3D models help companies to create an exact structure of the infected body part and do research effectively, the demand for 3D bioprinters increases. Additionally, cell culture made by those devices that mimic the human body helps in knowing the impact of those new drugs. Therefore, to ensure the proper development and functionality of new drugs, 3D bioprinting devices are highly used in research applications, and this dominance is expected to remain in the coming years as well.

Pharmaceuticals & Biotechnology Companies Generating Maximum Market Demand

Based on the end-user, pharmaceutical and biotechnology companies dominate the market with a share of around 64%. This is because more than 5,000 companies were present in the US in 2024 that are highly engaged in developing new products. To ensure the proper functionality of new products that they develop, they have to do clinical trials, which have become easier with the 3D models made by bioprinters. Therefore, due to the vast pharmaceutical industry and its testing needs, this segment has dominated the market in the past years, and this dominance is expected to continue in the future years as well.

Competitive Landscape

With strategic initiatives such as mergers, collaborations, and acquisitions, the leading market companies, including CELLINK, Organovo, Aspect Biosystems, Allevi, Prellis Biologics, Stratasys, Advanced Solutions Life Sciences LLC, regenHU Ltd., Poietis, 3D Bioprinting, and others, are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the country?
4. How has the industry been evolving in terms of geography & product adoption?
5. How has the competition been shaping up across the country?
6. How have buying behavior, customer inclination, and expectations from products been evolving during 2020-30?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?